Substance abuse is the repeated harmful use of any substance, including drugs and alcohol. The substances may be legal, prescription drugs or banned substances as well some that aren't even classified as drugs. Abuse can occur when you aren't using the substance the way it was recommended or because you are taking more than the prescribed dosage.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Substance Abuse Therapeutics industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Opioid Addiction
Tobacco/Nicotine Addiction
Alcohol Dependence
Market Segment by Product Application
Hospital & Clinics
Residential (non-hospital)
Finally, the report provides detailed profile and data information analysis of leading company.
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark
Dr. Reddy's Laboratories
Teva Pharmaceutical
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Substance Abuse Therapeutics consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Substance Abuse Therapeutics market by identifying its various subsegments.
3.Focuses on the key global Substance Abuse Therapeutics manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Substance Abuse Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Substance Abuse Therapeutics submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Substance Abuse Therapeutics Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Substance Abuse Therapeutics Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Substance Abuse Therapeutics Segment by Type
2.1.1 Opioid Addiction
2.1.2 Tobacco/Nicotine Addiction
2.1.3 Alcohol Dependence
2.2 Market Analysis by Application
2.2.1 Hospital & Clinics
2.2.2 Residential (non-hospital)
2.3 Global Substance Abuse Therapeutics Market Comparison by Regions (2017-2027)
2.3.1 Global Substance Abuse Therapeutics Market Size (2017-2027)
2.3.2 North America Substance Abuse Therapeutics Status and Prospect (2017-2027)
2.3.3 Europe Substance Abuse Therapeutics Status and Prospect (2017-2027)
2.3.4 China Substance Abuse Therapeutics Status and Prospect (2017-2027)
2.3.5 Japan Substance Abuse Therapeutics Status and Prospect (2017-2027)
2.3.6 Southeast Asia Substance Abuse Therapeutics Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Substance Abuse Therapeutics Industry Impact
2.5.1 Substance Abuse Therapeutics Business Impact Assessment - Covid-19
2.5.2 Market Trends and Substance Abuse Therapeutics Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Substance Abuse Therapeutics Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Substance Abuse Therapeutics Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Substance Abuse Therapeutics Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Substance Abuse Therapeutics Manufacturer Market Share
3.5 Top 10 Substance Abuse Therapeutics Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Substance Abuse Therapeutics Market
3.7 Key Manufacturers Substance Abuse Therapeutics Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Substance Abuse Therapeutics Industry Key Manufacturers
4.1 Indivior
4.1.1 Compan Detail
4.1.2 Indivior Substance Abuse Therapeutics Product Introduction, Application and Specification
4.1.3 Indivior 133 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Indivior News
4.2 Pfizer
4.2.1 Compan Detail
4.2.2 Pfizer Substance Abuse Therapeutics Product Introduction, Application and Specification
4.2.3 Pfizer Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Indivior News
4.3 Alkermes
4.3.1 Compan Detail
4.3.2 Alkermes Substance Abuse Therapeutics Product Introduction, Application and Specification
4.3.3 Alkermes Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Alkermes News
4.4 Novartis
4.4.1 Compan Detail
4.4.2 Novartis Substance Abuse Therapeutics Product Introduction, Application and Specification
4.4.3 Novartis Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Novartis News
4.5 Mylan
4.5.1 Compan Detail
4.5.2 Novartis Substance Abuse Therapeutics Product Introduction, Application and Specification
4.5.3 Mylan Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Mylan News
4.6 Cipla
4.6.1 Compan Detail
4.6.2 Cipla Substance Abuse Therapeutics Product Introduction, Application and Specification
4.6.3 Cipla Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Cipla News
4.7 Glenmark
4.7.1 Compan Detail
4.7.2 Glenmark Substance Abuse Therapeutics Product Introduction, Application and Specification
4.7.3 Glenmark Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Dr. Reddy's Laboratories
4.8.1 Compan Detail
4.8.2 Dr. Reddy's Laboratories Substance Abuse Therapeutics Product Introduction, Application and Specification
4.8.3 Dr. Reddy's Laboratories Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Dr. Reddy's Laboratories News
4.9 Teva Pharmaceutical
4.9.1 Compan Detail
4.9.2 Teva Pharmaceutical Substance Abuse Therapeutics Product Introduction, Application and Specification
4.9.3 Teva Pharmaceutical Substance Abuse Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Teva Pharmaceutical News
5 Global Substance Abuse Therapeutics Market Segment by Big Type
5.1 Global Substance Abuse Therapeutics Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Substance Abuse Therapeutics Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Substance Abuse Therapeutics Revenue and Market Share by Big Type (2017-2022)
5.2 Opioid Addiction Sales Growth Rate and Price
5.2.1 Global Opioid Addiction Sales Growth Rate (2017-2022)
5.2.2 Global Opioid Addiction Price (2017-2022)
5.3 Tobacco/Nicotine Addiction Sales Growth Rate and Price
5.3.1 Global Tobacco/Nicotine Addiction Sales Growth Rate (2017-2022)
5.3.2 Global Tobacco/Nicotine Addiction Price (2017-2022)
5.4 Alcohol Dependence Sales Growth Rate and Price
5.4.1 Global Alcohol Dependence Sales Growth Rate (2017-2022)
5.4.2 Global Alcohol Dependence Price (2017-2022)
6 Global Substance Abuse Therapeutics Market Segment by Big Application
6.1 Global Substance Abuse Therapeutics Sales Market Share by Big Application (2017-2022)
6.2 Hospital & Clinics Sales Growth Rate (2017-2022)
6.3 Residential (non-hospital) Sales Growth Rate (2017-2022)
7 Global Substance Abuse Therapeutics Forecast
7.1 Global Substance Abuse Therapeutics Revenue, Sales and Growth Rate (2022-2027)
7.2 Substance Abuse Therapeutics Market Forecast by Regions (2022-2027)
7.2.1 North America Substance Abuse Therapeutics Market Forecast (2022-2027)
7.2.2 Europe Substance Abuse Therapeutics Market Forecast (2022-2027)
7.2.3 China Substance Abuse Therapeutics Market Forecast (2022-2027)
7.2.4 Japan Substance Abuse Therapeutics Market Forecast (2022-2027)
7.2.5 Southeast Asia Substance Abuse Therapeutics Market Forecast (2022-2027)
7.2.6 Other Regions Substance Abuse Therapeutics Market Forecast (2022-2027)
7.3 Substance Abuse Therapeutics Market Forecast by Type (2022-2027)
7.3.1 Global Substance Abuse Therapeutics Sales Forecast by Type (2022-2027)
7.3.2 Global Substance Abuse Therapeutics Market Share Forecast by Type (2022-2027)
7.4 Substance Abuse Therapeutics Market Forecast by Application (2022-2027)
7.4.1 Global Substance Abuse Therapeutics Sales Forecast by Application (2022-2027)
7.4.2 Global Substance Abuse Therapeutics Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Substance Abuse Therapeutics Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Substance Abuse Therapeutics Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Substance Abuse Therapeutics
Figure Market Concentration Ratio and Market Maturity Analysis of Substance Abuse Therapeutics
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Substance Abuse Therapeutics Market Size by Big Type
Figure Global Market Share of Substance Abuse Therapeutics by Big Type in 2021
Figure Opioid Addiction Picture (2017-2022)
Figure Tobacco/Nicotine Addiction Picture (2017-2022)
Global Substance Abuse Therapeutics Market Size by Big Application
Table Global Substance Abuse Therapeutics Market Size by Application
Figure Global Substance Abuse Therapeutics Market Share by Big Application in 2021
Figure Hospital & Clinics Picture
Figure Residential (non-hospital) Picture
Table Global Substance Abuse Therapeutics Comparison by Regions (M USD) (2017-2027)
Figure Global Substance Abuse Therapeutics Market Size (Million US$) (2017-2027)
Figure North America Substance Abuse Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Substance Abuse Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure China Substance Abuse Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Substance Abuse Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Substance Abuse Therapeutics Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Substance Abuse Therapeutics Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Substance Abuse Therapeutics Sales by Manufacturer (2017-2022)
Figure Global Substance Abuse Therapeutics Sales Market Share by Manufacturer in 2021
Table Global Substance Abuse Therapeutics Revenue by Manufacturer (2017-2022)
Figure Global Substance Abuse Therapeutics Revenue Market Share by Manufacturer in 2021
Table Global Substance Abuse Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Substance Abuse Therapeutics Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Substance Abuse Therapeutics Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Substance Abuse Therapeutics Market
Table Key Manufacturers Substance Abuse Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Indivior Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Indivior
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Pfizer Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Pfizer
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Recent Development
Table Alkermes Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Alkermes
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alkermes Main Business
Table Alkermes Recent Development
Table Novartis Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Novartis
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Novartis Main Business
Table Novartis Recent Development
Table Mylan Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Mylan
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan Main Business
Table Mylan Recent Development
Table Cipla Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Cipla
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table Glenmark Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Glenmark
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Glenmark Main Business
Table Glenmark Recent Development
Table Dr. Reddy's Laboratories Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Dr. Reddy's Laboratories
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dr. Reddy's Laboratories Main Business
Table Dr. Reddy's Laboratories Recent Development
Table Teva Pharmaceutical Company Profile
Table Substance Abuse Therapeutics Product Introduction, Application and Specification of Teva Pharmaceutical
Table Substance Abuse Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Pharmaceutical Main Business
Table Teva Pharmaceutical Recent Development
Figure Global Substance Abuse Therapeutics Sales and Growth Rate (2017-2022)
Figure Global Substance Abuse Therapeutics Revenue and Growth Rate (2017-2022)
Table Global Substance Abuse Therapeutics Sales by Regions (2017-2022)
Figure Global Substance Abuse Therapeutics Sales Market Share by Regions in 2021
Table Global Substance Abuse Therapeutics Revenue by Regions (2017-2022)
Figure Global Substance Abuse Therapeutics Revenue Market Share by Regions in 2021
Figure North America Substance Abuse Therapeutics Sales and Growth Rate (2017-2022)
Figure Europe Substance Abuse Therapeutics Sales and Growth Rate (2017-2022)
Figure China Substance Abuse Therapeutics Sales and Growth Rate (2017-2022)
Figure Japan Substance Abuse Therapeutics Sales and Growth Rate (2017-2022)
Figure Southeast Asia Substance Abuse Therapeutics Sales and Growth Rate (2017-2022)
Figure Other Regions Substance Abuse Therapeutics Sales and Growth Rate (2017-2022)
Table Global Substance Abuse Therapeutics Sales by Big Type (2017-2022)
Table Global Substance Abuse Therapeutics Sales Market Share by Big Type (2017-2022)
Figure Global Substance Abuse Therapeutics Sales Market Share by Big Type in 2019
Table Global Substance Abuse Therapeutics Revenue by Big Type (2017-2022)
Table Global Substance Abuse Therapeutics Revenue Market Share by Big Type (2017-2022)
Table Global Substance Abuse Therapeutics Revenue Market Share by Big Type in 2019
Figure Global Opioid Addiction Sales Growth Rate (2017-2022)
Figure Global Opioid Addiction Price (2017-2022)
Figure Global Tobacco/Nicotine Addiction Sales Growth Rate (2017-2022)
Figure Global Tobacco/Nicotine Addiction Price (2017-2022)
Figure Global Alcohol Dependence Sales Growth Rate (2017-2022)
Table Global Substance Abuse Therapeutics Sales by Big Application (2017-2022)
Table Global Substance Abuse Therapeutics Sales Market Share by Big Application (2017-2022)
Figure Global Substance Abuse Therapeutics Sales Market Share by Big Application in 2019
Figure Global Hospital & Clinics Sales Growth Rate (2017-2022)
Figure Global Residential (non-hospital) Sales Growth Rate (2017-2022)
Figure Global Substance Abuse Therapeutics Sales and Growth Rate (2022-2027)
Figure Global Substance Abuse Therapeutics Revenue and Growth Rate (2022-2027)
Table Global Substance Abuse Therapeutics Sales Forecast by Regions (2022-2027)
Table Global Substance Abuse Therapeutics Market Share Forecast by Regions (2022-2027)
Figure North America Sales Substance Abuse Therapeutics Market Forecast (2022-2027)
Figure Europe Sales Substance Abuse Therapeutics Market Forecast (2022-2027)
Figure China Sales Substance Abuse Therapeutics Market Forecast (2022-2027)
Figure Japan Sales Substance Abuse Therapeutics Market Forecast (2022-2027)
Figure Southeast Asia Sales Substance Abuse Therapeutics Market Forecast (2022-2027)
Figure Other Regions Sales Substance Abuse Therapeutics Market Forecast (2022-2027)
Table Global Substance Abuse Therapeutics Sales Forecast by Type (2022-2027)
Table Global Substance Abuse Therapeutics Market Share Forecast by Type (2022-2027)
Table Global Substance Abuse Therapeutics Sales Forecast by Application (2022-2027)
Table Global Substance Abuse Therapeutics Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Substance Abuse Therapeutics
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Substance Abuse Therapeutics Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Substance Abuse Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Substance Abuse Therapeutics Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Substance Abuse Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Substance Abuse Therapeutics Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Substance Abuse Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Substance Abuse Therapeutics Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Substance Abuse Therapeutics Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Indivior
Pfizer
Alkermes
Novartis
Mylan
Cipla
Glenmark